The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option

Illness perception, mood and coping strategies in allergic rhinitis: are there differences among ARIA classes of severity?

(2018) F. Braido et al.   RHINOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

(2017) Jan L. Brożek et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children

(2016) W. Berger et al.   ALLERGY

MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study

(2016) Ludger Klimek et al.   ALLERGY AND ASTHMA PROCEEDINGS

MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

(2016) Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Sublingual or subcutaneous immunotherapy for allergic rhinitis?

(2016) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses

(2016) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment

(2016) William Berger et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

TOTALL: high cost of allergic rhinitis—a national Swedish population-based questionnaire study

(2016) Lars-Olaf Cardell et al.   npj Primary Care Respiratory Medicine

MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

(2015) J. Bousquet et al.   ALLERGY

Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: Results from a noninterventional study

(2015) Ludger Klimek et al.   ALLERGY AND ASTHMA PROCEEDINGS

Intranasal Spray Medications for Maintenance Therapy of Allergic Rhinitis

(2015) William E. Berger et al.   American Journal of Rhinology & Allergy

Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis

(2015) Paul Ratner et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

GEMA4.0. Guía española para el manejo del asma

(2015) Vicente Plaza Moral   ARCHIVOS DE BRONCONEUMOLOGIA

Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps

(2015) Jean Bousquet et al.   EXPERT OPINION ON PHARMACOTHERAPY

Operational Definition of Active and Healthy Aging (AHA): The European Innovation Partnership (EIP) on AHA Reference Site Questionnaire: Montpellier October 20–21, 2014, Lisbon July 2, 2015

(2015) Jean Bousquet et al.   Journal of the American Medical Directors Association

GEMA4.0. Guía española para el manejo del asma

(2015) Vicente Plaza Moral   ARCHIVOS DE BRONCONEUMOLOGIA

MP29-02* reduces eosinophil survival induced by epithelial cell secretions from nasal mucosa

(2015) Jordi Roca-Ferrer et al.   Clinical and Translational Allergy

Deposition characteristics of a new allergic rhinitis nasal spray (MP29-02*) in an anatomical model of the human nasal cavity

(2015) Alex D’Addio et al.   Clinical and Translational Allergy

The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey

(2015) David Price et al.   Clinical and Translational Allergy

Real-life effectiveness of a new allergic rhinitis therapy (MP29-02*) in Sweden

(2015) Pär Stjärne et al.   Clinical and Translational Allergy

Allergic rhinitis is a risk factor for traffic safety

(2014) E. F. P. M. Vuurman et al.   ALLERGY

Unique immunomodulatory effects of azelastine on dendritic cells in vitro

(2014) S. Schumacher et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo

(2014) Nan Zhang et al.   PLoS One

Underdiagnosed and Undertreated Allergic Rhinitis in Urban School-Aged Children with Asthma

(2014) Cynthia A. Esteban et al.   Pediatric Allergy Immunology and Pulmonology

Cysteinyl Leukotrienes and Their Receptors; Emerging Concepts

(2014) Yoshihide Kanaoka et al.   Allergy Asthma & Immunology Research

Long-term, Randomized Safety Study of MP29-02 (a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate in an Advanced Delivery System) in Subjects With Chronic Rhinitis

(2014) William E. Berger et al.   Journal of Allergy and Clinical Immunology-In Practice

Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation

(2013) Alison Thompson et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor

(2013) Michail Alevizos et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care

(2013) P. Demoly et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Clinically Relevant Effect of a New Intranasal Therapy (MP29-02) in Allergic Rhinitis Assessed by Responder Analysis

(2013) Eli Meltzer et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis

(2013) Carmen Rondón et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort survey

(2013) Mark Small et al.   Clinical and Translational Allergy

Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

(2012) P. W. Hellings et al.   ALLERGY

Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis

(2012) Warner W. Carr et al.   ALLERGY AND ASTHMA PROCEEDINGS

Editorial

(2012) Joseph A. Bellanti et al.   ALLERGY AND ASTHMA PROCEEDINGS

MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial of efficacy and safety

(2012) Eli O. Meltzer et al.   ALLERGY AND ASTHMA PROCEEDINGS

Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis

(2012) Hideyuki Yamamoto et al.   ALLERGY AND ASTHMA PROCEEDINGS

Burden of allergic rhinitis: Allergies in America, Latin America, and Asia-Pacific adult surveys

(2012) Eli O. Meltzer et al.   ALLERGY AND ASTHMA PROCEEDINGS

Allergic Rhinitis and Its Impact on Work Productivity in Primary Care Practice and a Comparison with Other Common Diseases: The Cross-sectional Study to Evaluate Work Productivity in Allergic Rhinitis Compared with Other Common Diseases (CAPRI) Study

(2012) Belén de la Hoz Caballer et al.   American Journal of Rhinology & Allergy

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29-02, a novel aqueous nasal spray

(2012) Hartmut Derendorf et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Impact of Allergic Rhinitis Symptoms on Quality of Life in Primary Care

(2012) Philippe Jean Bousquet et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis

(2012) Warner Carr et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Local allergic rhinitis: Concept, pathophysiology, and management

(2012) Carmen Rondón et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy of intranasal corticosteroids for the ocular symptoms of allergic rhinitis: A systematic review

(2011) Jison Hong et al.   ALLERGY AND ASTHMA PROCEEDINGS

Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis

(2011) Anne Marie Salapatek et al.   ALLERGY AND ASTHMA PROCEEDINGS

Use of Montelukast Alone or in Combination with Desloratadine or Levocetirizine in Patients with Persistent Allergic Rhinitis

(2011) Maciej Ciebiada et al.   American Journal of Rhinology & Allergy

Update of prevalence of self-reported allergic rhinitis and chronic nasal symptoms among adults in Sweden

(2011) Jonas Eriksson et al.   Clinical Respiratory Journal

Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analyses

(2011) Paolo Maria Matricardi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Antihistaminic, Anti-Inflammatory, and Antiallergic Properties of the Nonsedating Second-Generation Antihistamine Desloratadine: A Review of the Evidence

(2011) G. Walter Canonica et al.   World Allergy Organization Journal

An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis

(2010) Jorge F. Maspero et al.   ALLERGY AND ASTHMA PROCEEDINGS

Allergic and mixed rhinitis: Epidemiology and natural history

(2010) Jonathan A. Bernstein   ALLERGY AND ASTHMA PROCEEDINGS

Objective Improvement in Nasal Congestion and Nasal Hyperreactivity with Use of Nasal Steroids in Persistent Allergic Rhinitis

(2010) Gustavo F. Wandalsen et al.   American Journal of Rhinology & Allergy

Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis

(2010) Paul H. Ratner et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis

(2010) Robert Anolik   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Intranasal corticosteroids and the eye: from negative ocular effects to clinical efficacy as a class effect

(2010) Leonard Bielory   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device

(2010) Frank C. Hampel et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Rupatadine and Levocetirizine for Seasonal Allergic Rhinitis

(2010) Rituparna Maiti et al.   ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY

Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review

(2010) G. J. Rodrigo et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Congestion and Sleep Impairment in Allergic Rhinitis

(2010) Timothy J. Craig et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Efficacy of Desloratadine in Persistent Allergic Rhinitis – A GA2LEN Study

(2010) Jean Bousquet et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Uncontrolled allergic rhinitis during treatment and its impact on quality of life: A cluster randomized trial

(2010) Philippe J. Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 Revision

(2010) Jan L. Brożek et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Concentration-Dependent Noncysteinyl Leukotriene Type 1 Receptor-Mediated Inhibitory Activity of Leukotriene Receptor Antagonists

(2010) Grzegorz Woszczek et al.   JOURNAL OF IMMUNOLOGY

The Pathophysiology, Diagnosis and Treatment of Allergic Rhinitis

(2010) Yang-Gi Min   Allergy Asthma & Immunology Research

Efficacy of desloratadine in intermittent allergic rhinitis: a GA2LEN study

(2009) J. Bousquet et al.   ALLERGY

The prevalence of nasal symptoms attributed to allergies in the United States: Findings from the burden of rhinitis in an America survey

(2009) Robert A. Nathan et al.   ALLERGY AND ASTHMA PROCEEDINGS

Comparison of fluticasone furoate and fluticasone propionate for the treatment of Japanese cedar pollinosis

(2009) Kimihiro Okubo et al.   ALLERGY AND ASTHMA PROCEEDINGS

The impact of allergic rhinitis on sexual activity, sleep, and fatigue

(2009) Michael S. Benninger et al.   ALLERGY AND ASTHMA PROCEEDINGS

Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism

(2009) Ronald Anderson et al.   BRITISH JOURNAL OF PHARMACOLOGY

Intranasal corticosteroids: Do they improve ocular allergy?

(2009) Catherine Origlieri et al.   CURRENT ALLERGY AND ASTHMA REPORTS

Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis?

(2009) Paul K. Keith et al.   CURRENT MEDICAL RESEARCH AND OPINION

The voice of the patients: allergic rhinitis is not a trivial disease

(2009) Erkka Valovirta et al.   Current Opinion in Allergy and Clinical Immunology

Azelastine nasal spray for the treatment of allergic and nonallergic rhinitis

(2009) Friedrich Horak et al.   Expert Review of Clinical Immunology

Unmet needs in severe chronic upper airway disease (SCUAD)

(2009) Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey

(2009) Eli O. Meltzer et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis

(2009) Philippe-Jean Bousquet et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Pranlukast Attenuates Ischemia-like Injury in Endothelial Cells Via Inhibiting Reactive Oxygen Species Production and Nuclear Factor-κB Activation

(2009) San-Hua Fang et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

(2008) J. Bousquet et al.   ALLERGY

Montelukast inhibits tumour necrosis factor-α-mediated interleukin-8 expression through inhibition of nuclear factor-κB p65-associated histone acetyltransferase activity

(2008) F. Tahan et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data

(2008) Glenis K Scadding et al.   EXPERT OPINION ON PHARMACOTHERAPY

Montelukast inhibition of resting and GM-CSF-stimulated eosinophil adhesion to VCAM-1 under flow conditions appears independent of cysLT1R antagonism

(2008) A. J. Robinson et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Patient Perceptions of Allergic Rhinitis and Quality of Life

(2008) G. Walter Canonica et al.   World Allergy Organization Journal